Latest News about BIIB
Recent news which mentions BIIB
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
December 02, 2024
From Benzinga
From Motley Fool
Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
November 20, 2024
From Benzinga
Biogen's Outlook Dims As Analyst Projects Flat Revenue Until 2026
November 18, 2024
From Benzinga
From Benzinga
Disney To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Friday
November 15, 2024
From Benzinga
Peeling Back The Layers: Exploring Biogen Through Analyst Insights
November 14, 2024
Tickers
BIIB
From Benzinga
Biogen Analysts Slash Their Forecasts After Q3 Results
October 31, 2024
From Benzinga
This Kraft Heinz Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
October 31, 2024
From Benzinga
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
October 30, 2024
From Benzinga
Biogen's Q3 Profit Beats Expectations On Lower Multiple Sclerosis Revenues But New Products Offset Losses, Raises Profit Outlook
October 30, 2024
From Benzinga
From Motley Fool
From Benzinga
Larimar Therapeutics' New Drug Could Transform Treatment For Rare Neurological Disease, Analyst Sees Over 200% Upside For Stock
October 16, 2024
From Benzinga
From Benzinga
After Disappointing Parkinson's Data, Sage Therapeutics' Dalzanemdor Flunks Mid-Stage Alzheimer's Study
October 08, 2024
From Benzinga
Scholar Rock's Muscle Wasting Drug Excels In Pivotal Trial, Plans FDA Submission Next Year
October 07, 2024
From Benzinga
1 Unstoppable Growth Stock Heading to $2 Trillion by 2030
September 28, 2024
From Motley Fool
Biogen Terminates Collaboration With Sage Therapeutics For Neurological Disorder Candidate
September 26, 2024
From Benzinga
Biogen/UCB Partnered Autoimmune Disease Candidate Hits Primary Goal In Late-Stage Study, Sets Stage Another Pivotal Trial
September 24, 2024
From Benzinga
Forecasting The Future: 20 Analyst Projections For Biogen
September 23, 2024
Tickers
BIIB
From Benzinga
Zepbound And Mounjaro Maker Eli Illy Has A New CFO As It Navigates Regulatory Challenges: What You Should Know
September 09, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.